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Abstract
Background: MicroRNAs (miRNAs) play a fundamental role in the regulation of gene expression by translational
repression or target mRNA degradation. Regulatory elements in miRNA promoters are less well studied, but may
reveal a link between their expression and a specific cell type.
Results: To explore this link in myeloid cells, miRNA expression profiles were generated from monocytes and
dendritic cells (DCs). Differences in miRNA expression among monocytes, DCs and their stimulated progeny were
observed. Furthermore, putative promoter regions of miRNAs that are significantly up-regulated in DCs were
screened for Transcription Factor Binding Sites (TFBSs) based on TFBS motif matching score, the degree to which
those TFBSs are over-represented in the promoters of the up-regulated miRNAs, and the extent of conservation of
the TFBSs in mammals.
Conclusions: Analysis of evolutionarily conserved TFBSs in DC promoters revealed preferential clustering of sites
within 500 bp upstream of the precursor miRNAs and that many mRNAs of cognate TFs of the conserved TFBSs
were indeed expressed in the DCs. Taken together, our data provide evidence that selected miRNAs expressed in
DCs have evolutionarily conserved TFBSs relevant to DC biology in their promoters.
Background
In recent years, microRNAs (miRNAs) have taken center
stage, as they are key regulators of gene expression at the
post-transcriptional level, and play a fundamental role in
a wide variety of biological processes, such as cell growth,
development and several pathological conditions [1-3].
MicroRNAs are small, ~22 nt long, single-stranded mole-
cules which, when complexed with an RNA-induced
silencing complex (RISC), are able to form a complemen-
tary double-stranded RNA structure by hybridizing to
the 3’ untranslated region of target transcripts, and inhi-
bit translation of their cognate mRNA and/or promote
their degradation [4]. MicroRNAs have an established
role in hematopoietic development and immunity. For
example, forced expression of miR-181 in hematopoietic
progenitors leads to an increase in the number of B cells
[5], whereas it sets T cell receptor signaling thresholds by
targeting negative regulators [6]. MicroRNA-146a is up-
regulated during toll-like receptor (TLR) signaling and
targets TNF receptor-associated factor 6 (TRAF6) and
IL-1 receptor-associated kinase 1 (IRAK1) [7], thereby
serving in a negative feedback loop. Moreover, miR-155
is also up-regulated during TLR and TNF signaling [8],
and is required for normal immune function [9-14].
Although great strides have been made towards under-
standing the biogenesis of miRNAs [4] and the identifica-
tion of mRNA targets [15], their own expression is one of
the least understood aspects. They are transcribed by
RNA polymerase II [16] or RNA polymerase III [17]. In
addition, approximately 80% of miRNAs are located in
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introns of protein coding genes, but at least one third is
believed to be transcribed independently from their host
gene [4,18-20], whereas recent data suggest that most, if
not all, intronic miRNAs contain putative promoters
independent of their host gene [21]. In fact, it is now
believed that once physically accessible, a gene is regu-
lated by transcription factors that bind to their cognate
transcription factor binding site (TFBS) in its promoter.
Usually, there is more than one TFBS per gene, allowing
combinations of transcription factors to elicit gene tran-
scription. This phenomenon has been predicted for
instance in Plasmodium falciparum, a parasite with a
dearth of transcription-associated factors [22-24] and has
been experimentally validated in other eukaryotic promo-
ters [25,26].
Myeloid dendritic cells (DCs) and monocytes arise from
a common monocyte/dendritic cell progenitor [27]. In
vitro, DCs can be generated from blood-derived mono-
cytes when cultured in the presence of the cytokines inter-
leukin 4 (IL4) and granulocyte/macrophage colony
stimulating factor (GM-CSF) [28]. DCs play an important
role in innate immunity and the initiation of adaptive
immune responses. They capture foreign antigens in per-
ipheral tissues, migrate to the T-cell areas of secondary
lymphoid organs and present these antigens to T- and B-
cells. Depending on the extracellular signals they receive,
they either induce tolerance in the steady state (tolero-
genic DCs), or an inflammatory response in the presence
of pathogen-associated patterns (PAMPs) or inflammatory
cytokines (activated or mature DCs) [29,30]. As a conse-
quence, DCs have gained considerable interest as vaccine
adjuvants and are currently exploited in the treatment of
cancer after loading with tumor-cell derived antigens
[31,32].
In order to gain insight in miRNAs that may regulate
DC development and behaviour, expression profiles of 157
miRNAs were obtained from monocytes and DCs under
inflammatory and tolerizing conditions. We show that
DCs express a wide variety of miRNAs, some of which are
differentially regulated during DC development and
maturation. We predicted several target genes for these
miRNAs, as well as binding sites for transcription factors
in the putative promoter regions of these miRNAs.
Furthermore, we show that by also taking evolutionary
conservation [33,34] of the identified TFBSs into account,
binding sites were found to preferentially cluster within
500 bp upstream of the pre-miRNAs. Also, the fraction of
conserved TFBSs for which the cognate transcription fac-
tors are expressed in DCs increases with the number of
miRNA promoters that contain these TFBSs. Taken
together, the data described here provide evidence that the
promoter regions of the miRNAs expressed in myeloid
DCs contain binding sites for motifs of transcription fac-
tors that are relevant to myeloid cell biology. This may
help expand the understanding of the molecular mechan-
isms underlying DC biology and development.
Methods
Isolation, culture and characterization of monocytes and
DCs
Peripheral blood mononuclear cells (PBMCs) were iso-
lated as previously described [28]. Monocytes were iso-
lated from PBMCs using CD14+ selection and the
AutoMACS technology (Miltenyi Biotec, Bergisch Glad-
bach, Germany) following the manufacturer’s directions.
Human monocyte-derived DCs were generated using
GM-CSF and IL-4 and matured as described previously.
Purity and maturation of monocytes and DCs were
assessed by means of FACS analysis as described pre-
viously [28]. Mixed lymphocyte reactions were essentially
carried out as described elsewhere [35]. Briefly, they were
co-cultured with peripheral blood lymphocytes in various
dilutions for 2 to 4 days. Then tritiated thymidine (1 μCi/
well; MP Biomedicals) was added to the cell cultures and
incorporation was measured after 16 hr. Enzyme-linked
immunosorbent assays (ELISA) were performed to assess
the secretion of the inflammatory cytokines TNFa and
IL8, using BD OptEIA (BD Biosciences, San Jose, CA) kits
following the manufacturer’s recommendations.
Isolation of total RNA and microRNA-specific reverse
transcription and quantitative PCR
Total RNA was isolated using TRIzol (Invitrogen, Carls-
bad, CA), following the manufacturer’s recommendation.
Quantity and purity were determined spectrophotometri-
cally. For each miRNA, 4 ng of total RNA was used as
input and miRNAs were converted to cDNA using the
TaqMan miRNA Reverse Transcription cDNA Synthesis
kit and miRNA-specific looped primers from the Early
Access miRNA Profiling Kit (both from Applied Biosys-
tems, Foster City, CA) following the manufacturer’s
recommendations. Real-time quantitative PCR was per-
formed using miRNA-specific primer/probe pairs from the
Early Access miRNA Profiling Kit and reactions were car-
ried out as described elsewhere [36]. Actual amplification
and data collection were performed on the ABI 7700
Sequence Detection System (Applied Biosystems, Foster
City, CA). After visual inspection, data were exported to a
text file and further analyzed in Microsoft Excel (Microsoft
Corporation, Redmond, WA) and various Bioconductor
packages [37] in the R statistics environment [38].
Statistics for miRNAs expression data
Delta Ct values for each miRNA were calculated with
hsa-let-7a as a reference, according to the manufacturer’s
directions. Only miRNAs with a dCt ≤ 12 (where dCt =
Cttarget - Cthsa-let-7a) were considered for further analysis.
Data were combined into a convenient ExpressionSet
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(eSet) structure using the Biobase package, and further
analyzed by means of gene-by-gene one-factor ANOVA
using the package LMGene, all in Bioconductor and R.
Only genes that had a False Discovery Rate-adjusted
p-value of < 0.05 were considered differentially expressed.
These genes were further assessed using non-parametric
pairwise comparison of the different myeloid cell subsets
using Tukey’s post-hoc test in the R statistics package.
Genes with a p-value < 0.05 were considered differen-
tially expressed.
Determination of TFBSs in microRNA promoters
Putative promoter regions extending 2 kb upstream of
the miRNAs were extracted from the Genome Browser
sno/miRNA track of the UCSC March 2006 human gen-
ome assembly [39,40]. The program Clover [41] was used
to screen for over-represented TFBSs in these sequences
using a precompiled library of TFBS motifs. The library
contained 263 TFBS motifs (position-specific weight
matrices) constructed from the JASPAR core database
(2005) [42] and TRANSFAC version 7.0 [43].
To determine over-represented TFBS motifs, Clover
starts for every location in a DNA sequence, by calculating
a score reflecting the likelihood that a certain TF binds at
that location. This score is a likelihood ratio, with in the
numerator the probability that the sequence matches the
positional weight matrix of the motif (the product of the
frequencies of the nucleotides in the weight matrix at the
positions corresponding to those in the sequence) and in
the denominator the likelihood that the sequence is
derived from a random sequence (the product of the fre-
quencies of the nucleotides in each position in the back-
ground sequence). This likelihood ratio is then averaged
per complete sequence and over all subsets of the set of
sequences. Finally a “raw score” is derived, by taking the
logarithm of the averaged likelihood ratio. A raw score
above zero thus signifies over-represented motifs and a
raw score below zero signifies under-represented motifs.
The raw score increases when more of the sequences con-
tain good motif matches, and also when there are more
good matches per sequence. The p-values for over-repre-
sented motifs are subsequently derived by analyzing,
whether random sets of promoter sequences from all the
genes in the genome are likely to have the same, or a
higher “raw score”. Clover examines the over-representa-
tion of multiple TFBSs and takes into account the multiple
testing issue for its p-value calculation. Besides the raw
score, Clover also reports an instance score, which is the
logarithm of the likelihood ratio mentioned above for any
specific TFBS at any specific position in the sequence.
Our inputs to Clover are the miRNA promoter
sequences and the 263 TFBS motifs mentioned above.
For statistical calculations, promoter regions 2 kb
upstream of all human genes in the genome are included
as background. Our thresholds for Clover outputs are
instance score ≥ 6 for recognizing a specific TFBS, and
p-value ≤ 0.05 for over-represented motifs (default values
in Clover). In addition, any mention of a TF motif score in
subsequent sections refers to the instance score for the
TFBS at a specific location in a promoter sequence. Our
motivation for including instance scores is to enable us to
calculate the conservation of the nucleotides at high-scor-
ing TFBSs.
Calculation of evolutionary conservation score of TFBSs
In order to take into account conservation of TFBSs in the
miRNA promoters, the PhastCons conservation track
from the UCSC Genome Browser of January 2009 (http://
hgdownload.cse.ucsc.edu/goldenPath/hg18/phastCons44-
way/) was used, which represents the conservation of each
nucleotide across 44 placental mammals as calculated
using the PhastCons program [33]. The mammalian con-
servation track was used because we examined the expres-
sion of mammalian miRNAs that are generally not
conserved outside this clade [44,45]. The base-by-base
conservation scores are derived from a two-state phylo-
HMM and are defined as the posterior probability that the
corresponding alignment column was generated by the
conserved state and not the non-conserved state of the
phylo-HMM used in the calculation [33]. The score ranges
from 0 to 1; the higher the value, the more conserved the
nucleotide. Using in-house Python scripts, we obtained
the conservation score for a TFBS as the median of the
PhastCons scores of the bases in that TFBS.
Microarray sample preparation of DCs and microarray
analysis
From one donor, 3 different samples (1 × 107 cells; tech-
nical replicate) were generated per DC subtype (imma-
ture monocyte-derived DCs, maturing DCs, tolerogenic
DCs and activated tolerogenic DCs) and RNA for micro-
array analysis was isolated using the RNeasy Total RNA
Extraction kit (Qiagen, Venlo, the Netherlands). Quality
control, conversion to labeled RNA, hybridization and
scanning were all performed at the microarray facility of
the Department of Human Genetics (Radboud University
Nijmegen Medical Centre Nijmegen, Nijmegen, the
Netherlands), using Affymetrix technology while follow-
ing the manufacturer’s protocols. The .CEL files were
processed using the Bioconductor package limma in the
R statistics environment and further analyzed with the
package panp to generate presence/absence calls from
the microarray data. In this study, intensities above the
p-value cut-off of 0.01 indicated presence, p-values
between 0.01 and 0.02 indicated marginal presence, and
p-values above 0.02 indicated absence. Complete,
MIAME-compliant datasets were deposited with the
Gene Expression Omnibus of the National Center for
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Biotechnology Information (http://www.ncbi.nlm.nih.
gov/geo/) and can be accessed through GEO Series
accession number GSE23371.
Analysis of miRNA targets
In addition to identifying miRNAs that are expressed in
DCs and monocytes, it is important to identify some of
their target genes. This may help in understanding the
miRNA-related molecular mechanisms underpinning DC
maturation. We used TargetScanHuman version 5.1 [15]
to predict the target genes for the miRNAs identified to
be expressed in DCs and monocytes. The precompiled
predictions were downloaded from the official TargetS-
can website (http://www.targetscan.org/) and were
further filtered for RefSeq transcripts having at least one
site that is conserved across placental mammals and also
had a target score (total context score) of ≤ -0.4 before
further analyses. To improve the reliability of the target
genes predicted, we used a second miRNA target predic-
tion tool, PicTar [46]. The precompiled miRNA target
predictions were downloaded from the PicTar website at
http://pictar.mdc-berlin.de, on January 2011. We filtered
the predictions at a PicTar threshold of ≥0.4. For further
analysis we used the target genes that were predicted by
both TargetScan and PicTar and also by each of the algo-
rithms separately. To narrow the scope of the target
genes to DCs, we used the previously published dataset
of Lehtonen and colleagues wherein the relative expres-
sion levels of gene expression in DCs relative to mono-
cytes are reported [47]. Using their data, we selected
genes that are at least 2-fold down-regulated in DCs rela-
tive to monocytes and that we also predicted to be target
genes for DC-expressed miRNAs. Comparisons between
our predicted target genes and genes that were over- or
under-expressed in DCs relative to monocytes in the
Lehtonen dataset were done at the level of RefSeq DNA
ID to ensure that the correct gene isoforms were being
matched. (The Lehtonen dataset was based on global
gene expression analyses using Affymetrix HG-U133A
Gene Chip oligonucleotide arrays. We used Biomart in
Ensembl version 62 available at http://www.ensembl.org/
biomart to obtain the corresponding RefSeq DNA IDs
for the probesets in the microarray dataset). The set of
genes so selected are likely to be important in miRNA
regulation of DC maturation from monocytes.
Gene Ontology analysis
Gene ontology enrichment analyses were done using the
Cytoscape [48] plugin BINGO version 2.3 [49]. Using this
software, we tested for over-representation using the
hypergeometric test with Benjamini & Hochberg False
Discovery Rate (FDR) correction. GO processes reported
were deemed significant when the corrected p-value was <
0.05. Venn diagrams were drawn using the Venny tool of
Oliveros, J.C. available at http://bioinfogp.cnb.csic.es/tools/
venny/index.html.
Results
Monocytes and monocyte-derived dendritic cell subtypes
express distinct microRNAs
Monocytes were isolated to > 90% purity and monocyte-
derived dendritic cell subtypes were generated and
validated as depicted in Additional file 1, Figure S1. A
TaqMan-based quantitative RT-PCR method was used to
profile the expression of miRNAs. Immature monocyte-
derived DCs (iDCs) were induced to either undergo
maturation by LPS stimulation for 6 hr (mDCs), to mature
into tolerogenic DCs (tDCs) in the presence of IL-10 and
dexamethasone for 24 hr, or to mature into activated tol-
erogenic DCs (atDCs; previously described by Emmer et
al. [50]) in the presence of IL-10 and dexamethasone for
24 hr, followed by 6 hr of LPS (Additional file 1, Figure
S1A). Phenotypical and functional characterization con-
firmed that mature DCs expressed high levels of CD80
and CD86 (Additional file 1, Figure S1B), induced strong
proliferation of allogeneic T cells in a mixed lymphocyte
reaction (Additional file 1, Figure S1C) and secreted high
levels of pro-inflammatory cytokines TNF and IL8 (Addi-
tional file 1, Figure S1D). Accordingly, iDCs and tDCs did
not show up-regulation of CD80 and CD86, induced
much less proliferation and produced less cytokines. Acti-
vated tolerogenic DCs showed a more intermediate pat-
tern of activation, indicative of less profound TLR
signaling in response to LPS. The expression profile of 157
miRNAs in monocytes and the various DC activation
stages was determined in a primary screen involving
total RNA from one donor as shown in Additional file 2,
Figure S2.
Of the 157 miRNAs screened, 104 were detected and
expressed to variable degrees in monocytes and/or DCs,
whereas 53 miRNAs remained undetected, irrespective
of cell type or stimulus (Additional file 3, Table S1).
Intriguingly, 27 miRNAs appeared to be differentially
expressed between monocytes, DCs and stimulated DCs
(Table 1). These 27 miRNAs were selected for additional
profiling of multiple donors as described below.
Identification of miRNAs differentially regulated during
monocyte-derived DC activation
To validate the expression of the identified 27 miRNAs,
their expression was further examined in monocytes and
DCs of 3 different donors (Additional file 2, Figure S2).
Statistical analysis revealed that 18 miRNAs were truly
differentially expressed (gene-by-gene ANOVA, p < 0.05;
Table 2). Six miRNAs were up-regulated in monocytes
versus DCs, and 10 were up-regulated in DCs versus
monocytes. Eight miRNAs were not differentially
expressed and had a high degree of variation in
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expression levels (data not shown). However, hsa-miR-
15b and hsa-miR-16 showed remarkably similar expres-
sion profiles and are expressed at higher levels in mono-
cytes (Figure 1, upper row of charts; Pearson correlation
= 0.99). Hsa-miR-125a, hsa-miR-221 and hsa-miR-342
are examples of miRNAs that are up-regulated in the DC
populations relative to monocytes (Figure 1, middle row).
Furthermore, both hsa-miR-146a and hsa-miR-155 were
up-regulated during differentiation, and were slightly up-
regulated in mDCs and atDCs (Figure 1, two left charts
in lower row; gene-by-gene ANOVA, p < 0.05, Tukey’s
post-hoc test; Pearson correlation = 0.90), whereas hsa-
miR-210 was primarily up-regulated in atDCs (Figure 1,
right chart of lower row). Data generated from these ana-
lyses indicate that many of the selected miRNAs are
indeed expressed in monocytes and DCs, and that 3 of
these miRNAs are differentially regulated during DC
development and maturation.
Identification of TFBSs in promoters of differentially
expressed miRNAs in monocytes and DCs
In order to link the miRNA expression profiles to a spe-
cific TFBS (or groups of TFBSs) of the myeloid cell
types that were analyzed, sequences 2 kb upstream of
the mapped pre-miRNAs were chosen for analysis. It
should be noted that it is expected that a majority of
miRNAs contain their own promoters [21], and that in
some cases, different miRNA genes (such as hsa-miR-
16-1 and hsa-miR-16-2) in the genome give rise to an
identical mature miRNA (such as hsa-miR-16). There-
fore 31 promoters could be assigned to 27 miRNAs that
were profiled in detail (Table 1). Likewise, 167 promo-
ters could be assigned to the total of 157 miRNAs ana-
lyzed. Analysis of the 31 promoters revealed that 3
TFBS motifs (Elk-1, RREB-1 and SPIB) were over-repre-
sented using the Clover criteria (p < 0.05) among all 8
promoter sequences of miRNA genes that are up-regu-
lated in monocytes, and to have at least 1 high-scoring
TFBS (instance score ≥ 6) in each promoter. Selecting
TFBSs using these same criteria (over-represented
motifs and at least 1 high-scoring TFBS per promoter)
among the 12 promoters of the miRNAs that are up-
regulated in DCs relative to monocytes, reveals that they
have 13 TFBSs in common (Figure 2, Table 3, Addi-
tional file 4, Table S2). Furthermore, 4 TFBSs are over-
represented in the promoters in all of the 8 miRNAs
Table 1 MicroRNAs rescreened after primary screen in monocytes and dendritic cells, and their differences in
expression level between cell types
MicroRNA in
assay
Mature miRNA Sequence Current genomic entries in miRbase
matching mature miRNA
Up in
DC
Up in DC
subset
Up in
monocytes
No
difference
hsa-let-7e UGAGGUAGGAGGUUGUAUAGU same X
hsa-miR-15b UAGCAGCACAUCAUGGUUUACA same X
hsa-miR-16 UAGCAGCACGUAAAUAUUGGCG hsa-miR-16-1, hsa-miR-16-2 X
hsa-miR-27a UUCACAGUGGCUAAGUUCCGCC same X
hsa-miR-27b UUCACAGUGGCUAAGUUCUG same X
hsa-miR-34a UGGCAGUGUCUUAGCUGGUUGU same X
hsa-miR-99a AACCCGUAGAUCCGAUCUUGUG same X
hsa-miR-100 AACCCGUAGAUCCGAACUUGUG same X
hsa-miR-125a UCCCUGAGACCCUUUAACCUGUG same X
hsa-miR-125b UCCCUGAGACCCUAACUUGUGA hsa-miR-125b-1, hsa-miR-125b-2 X
hsa-miR-126 UCGUACCGUGAGUAAUAAUGC same X
hsa-miR-130a CAGUGCAAUGUUAAAAGGGC same X
hsa-miR-132 UAACAGUCUACAGCCAUGGUCG same X
hsa-miR-135a UAUGGCUUUUUAUUCCUAUGUGA hsa-miR-135a-1, hsa-miR-135a-2 X
hsa-miR-137 UAUUGCUUAAGAAUACGCGUAG same X
hsa-miR-140 AGUGGUUUUACCCUAUGGUAG same X
hsa-miR-146 UGAGAACUGAAUUCCAUGGGUU hsa-miR-146a X
hsa-miR-150 UCUCCCAACCCUUGUACCAGUG same X
hsa-miR-155 UUAAUGCUAAUCGUGAUAGGGG same X
hsa-miR-186 CAAAGAAUUCUCCUUUUGGGCUU same X
hsa-miR-199b CCCAGUGUUUAGACUAUCUGUUC same X
hsa-miR-199-s CCCAGUGUUCAGACUACCUGUU hsa-miR-199a-1, hsa-miR-199a-2 X
hsa-miR-210 CUGUGCGUGUGACAGCGGCUG same X
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that did not show any appreciable difference in expres-
sion levels (Table 3). The complete set of high-scoring
TFBSs found in the promoters of the miRNAs that are
up-regulated in DCs and monocytes are summarized in
Figure 3 and Additional file 5, Figure S3 respectively.
Clover detects motifs that are over-represented relative
to their expected frequencies and calculates p-values
based on a comparison with all promoters in the gen-
ome. Nevertheless such predictions can potentially give
rise to false positives, as even random sets of miRNA
promoters contain some over-represented motifs (Figure
3B). We therefore also examined the over-representation
of motifs in the promoters of DC and monocyte miR-
NAs relative to those of random sets of miRNAs,
selected from the total set of 167 miRNA promoters.
The 12 miRNAs that are over-expressed in DCs share
more TFBS motifs than do random sets of 12 miRNA
promoters, specifically with respect to motifs that are
shared by many of the promoters (Figure 3B). When
quantifying the number of shared motifs as the sum of
all occurrences of all Clover detected motifs, across all
promoters, we observe an enrichment of 1.96 relative to
randomly selected miRNA promoters (p = 0.001). Like-
wise, using random sets of 8 miRNA promoters, we
observed that the 8 miRNAs that are over-expressed in
monocytes have a factor of 1.58 enrichment of TFBS
motifs (p = 0.046; Additional file 5, Figure S3B). The p-
value here was estimated as the number of times, out of
1000, when a randomly chosen set of miRNA promoters
had at least an equal number of motifs as did the test
set of sequences. Given the significant over-representa-
tion of different sets of TFBSs in the different sets of
miRNAs, it appears that miRNAs contain multiple, dif-
ferent TFBSs in their promoters that specify their
expression in certain cell types. This is in agreement
with other studies that show that transcription factors
often work in combinations [25,26].
Evolutionary conservation and distribution of TFBSs in
the promoter sequences of myeloid miRNAs
Assuming that regulation of miRNA expression is con-
served among mammals, we used the PhastCons evolu-
tionary conservation track that is based on nucleotide
conservation among placental mammals (http://hgdown-
load.cse.ucsc.edu/goldenPath/hg18/phastCons44way/) to
quantify evolutionary conservation of the predicted
TFBSs. We compared both the motif instance scores
and raw scores of TFBSs, as derived from Clover, with
the nucleotide conservation score of the TFBSs. Applied
to the 2 kb upstream sequences of the pre-miRNAs that
are up-regulated in DCs, a small but significant correla-
tion of 0.12 (p = 6.17 × 10-7) was observed between the
conservation scores and the TFBS instance scores. Simi-
lar results were obtained using the raw score (r = 0.22,
p = 8.99 × 10-2). An overlay of TFBS instance scores
and conservation scores for the DC miRNA promoters
is depicted in Figure 4A. The positive but weak correla-
tion between TFBS motif scores and conservation scores
suggests that they are largely independent measures and
as such, combination of the two as a filtration measure
would be non-redundant. When filtering predicted sites
based both on their conservation and on their TFBS
instance scores, TFBSs tend to cluster in a region 500
bp just upstream of the putative TSS of miRNA genes
that are over-expressed in DCs (Figure 4B). This result
corroborates other findings indicating that TFBSs tend
to cluster near the transcription start site (TSS) of genes
[51-54]. In addition, it suggests that combining the
Table 2 Assignment of p-values for expressed miRNAs in
all cell types (monocytes and various DC subsets) and DC
subsets alone after ANOVA
Posterior p-values*
miRNA gene All cell types DC subsets
hsa-let-7e 1.9E-05 4.2E-01
hsa-miR-15b 1.2E-04 6.8E-01
hsa-miR-16 2.1E-02 7.8E-01
hsa-miR-27a 3.0E-01 2.5E-01
hsa-miR-27b 8.2E-01 8.2E-01
hsa-miR-34a 3.0E-05 9.6E-01
hsa-miR-99a 2.2E-06 7.2E-01
hsa-miR-100 3.7E-06 7.3E-01
hsa-miR-125a 1.3E-04 8.6E-01
hsa-miR-125b 1.6E-05 7.2E-01
hsa-miR-126 6.1E-01 7.7E-01
hsa-miR-130a 1.6E-03 4.4E-01
**hsa-miR-132 4.0E-02 9.8E-01
hsa-miR-135a 7.1E-10 9.1E-02
hsa-miR-137 3.2E-07 2.1E-01
hsa-miR-140 8.2E-01 7.1E-01
hsa-miR-146a 9.6E-05 1.3E-02
***hsa-miR-150 9.9E-02 7.1E-01
hsa-miR-155 4.7E-06 2.5E-02
hsa-miR-186 7.2E-01 6.9E-01
hsa-miR-199b 5.2E-05 7.1E-01
hsa-miR-199s 8.4E-03 4.4E-01
hsa-miR-210 1.3E-05 4.0E-02
hsa-miR-221 5.6E-06 7.4E-01
hsa-miR-326 7.4E-01 9.7E-01
hsa-miR-340 8.6E-01 7.9E-01
hsa-miR-342 6.1E-06 9.9E-01
*) Posterior p-values < 0.05 indicate differential expression among subsets.
**) Considered not expressed differentially after visual inspection of gene
expression data.
***) Considered expressed differentially after visual inspection of the data.
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motif matching score with the extent of evolutionary
conservation of a TFBS would likely reveal TFs biologi-
cally relevant to the identified set of miRNA promoters.
In further support of the conservation of the binding
motifs that are over-represented in the promoters of the
DC-expressed miRNAs, we created a set of random
sequence blocks of the same length-distribution as the
predicted TFBSs from the same promoters as the test
set. From these two data sets, we observed that the pre-
dicted TFBSs are significantly (p = 1.49 × 10-3, Wil-
coxon rank sum test) more conserved than randomly
chosen sequences. The conservation score assigned to a
TFBS is the median of the PhastCons scores of the
bases in that TFBS segment. We observed that the med-
ian of the conservation scores of the test TFBSs is more
than 2 fold higher than that of the random sequences
(Figure 4C). The complete set of conserved high-scoring
TFBSs found in the promoters of the miRNAs up-regu-
lated in DCs and monocytes are summarized in Figure 5
and Additional file 6, Figure S4 respectively. Further-
more, we observed at the threshold of 10th percentile of
median TFBS conservation, that the miRNAs that are
over-expressed in DCs share more (fold = 3.51, p <
0.001) sites for TF motifs than did 1000 random sets of
promoters of equal size, length and at the same conser-
vation threshold (Figure 5B). A similar result (fold =
3.48, p = 0.003) was obtained for the miRNAs that were
over-expressed in monocytes (Additional file 6, Figure
S4B). These results show that evolutionary conserved
TFBSs are more common in the promoters of miRNAs
over-expressed in DCs and monocytes than in randomly
chosen miRNA promoters.
Integrating the motif-matching and evolutionary
conservation scores of TFBSs and further validation of
cognate TFs in microarray data from DCs
Without taking evolutionary information into account, 13
TFBSs were found to occur at least once in all the promo-
ters of miRNAs preferentially expressed in DCs (Figure 2).
Filtering TFBSs at 10th percentile threshold of the TFBS
conservation scores not surprisingly identifies TFBSs that
are common to far less miRNAs promoters (Figure 5).
Among these, the TFBS of MZF1 was the most conserved
at the thresholds used. To validate the expression of the
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Figure 1 Expression profiles of various miRNAs that are differentially expressed in monocytes and DCs. The upper two charts represent
miRNAs over-expressed in monocytes, the middle row of charts represent 3 of the miRNAs over-expressed in DCs, and the lower row of charts
represent the 3 miRNAs that are differentially expressed among subsets of DCs. On the Y-axis relative expression is depicted, which is normalized
to the expression of hsa-let-7a.
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cognate transcription factors whose binding site was iden-
tified, a transcriptome was generated of DCs from one
donor using microarrays. The resulting data were screened
for the presence or absence of transcription factors (TFs)
whose binding sites were predicted in promoters of miR-
NAs up-regulated in DCs. For 10 out of the 17 TFBSs that
are over-represented among the DC promoters (Addi-
tional file 4, Table S2B) and that contained at least one
TFBS with an instance score of at least 6.0 and a conserva-
tion threshold score of 0.968 (i.e. the 10th percentile of the
median conservation scores of all TFBSs predicted in the
set of miRNA promoters) as shown in Figure 5, the
mRNA encoding their cognate TF was expressed in DCs.
Expression of this 58.8% of the predicted over-represented
TFs is slightly higher than that for all the TFs that were
examined with the microarrays (54% expressed, 46% not
expressed, Additional file 7, Table S3). Nevertheless, we
found a high correlation (r = 0.91, p = 1.17 × 10-2) when
the number of motifs of expressed TFs was correlated
with the number of miRNA promoters in which the motifs
of these TFs were detected (Additional file 8, Figure S5A).
An insignificant correlation (r = -0.72, p = 4.88 × 10-1)
was observed when a random set of miRNA promoters
was used (Additional file 8, Figure S5B).
Gene Ontology of the expressed TFs highlighted
immune-related processes like “interspecies interaction
between organisms” (p = 4.49 × 10-5) and “regulation of
T-helper 2 type immune response” (p = 1.19 × 10-2,
Additional file 9, Table S4A). This is in line with the
expected functions of DCs in immune response. Mean-
while, Gene Ontology of the TFs that were not
expressed highlighted development-related processes
like “cell development” (p = 1.88 × 10-3) and “cell fate
commitment” (p = 7.54 × 10-3, Additional file 9, Table
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Figure 2 Representation of TFBSs in promoter regions of miRNAs up-regulated in DCs. Depicted are the TFBSs at a motif instance score
threshold of at least 6 in the miRNA promoter regions. The scale of the y-axis ranges from 5 to 15 for each subgraph. The legend shows only
those TFBSs that are present in all promoter sequences.
Table 3 TFBSs that are present in all miRNA promoters in a particular (group of) cell type(s)
Cell types Overrepresented TFBS
Monocytes Elk-1, RREB-1, SPIB
DCs* AP-4, E47, MAZR, Myf, MZF1, RREB1, RREB-1, Sp1, SPI1, SPIB, STAT6, ZNF42_1-4, ZNF42_5-13
Subset of DCs** AP-1, ARP-1, FOXI1, myogenin/NF-1, Ncx, Oct-1, OCT-x, Sp1, TCF11, ZNF42_1-4
All cells*** Oct-1, RP58, SPIB, USF
*) Includes monocyte-derived iDCs, maturing DCs, tolerogenic DCs and activated tolerogenic DCs
**) Includes maturing DCs and/or activated tolerogenic DCs
***) Concerns all cells investigated, and miRNAs did not show appreciable differences in expression level
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S4B), with little relevance to immune-related processes.
Taken together, these data provide evidence that many
expressed miRNAs in DCs have evolutionarily conserved
TFBSs that may be relevant to DC biology in their
promoters.
Target prediction and Gene Ontology analysis of
microRNAs enriched in monocytes and DCs
To extend the regulatory pathways in which the miRNAs
participate downstream, we predicted miRNA targets,
using TargetScanHuman version 5.1 [15] and PicTar
[46]. Both datasets were based on conservation in mam-
mals. We obtained the precompiled dataset from their
official websites. At a TargetScan context score threshold
of at most -0.4, we obtained 421 distinct target genes
(Additional file 10, Table S5; counting in RefSeq DNA
IDs) for the miRNAs that are over-expressed in DCs.
Meanwhile at a PicTar score threshold of at least 0.4, we
obtained 2300 distinct target genes (Additional file 11,
Table S6) for the miRNAs over-expressed in DCs. Like-
wise, we predicted 282 (Additional file 12, Table S7) and
1591 (Additional file 13, Table S8) distinct genes using
A
B
Figure 3 TFBSs shared among the promoter regions of miRNAs up-regulated in DCs. (A) Shown on the x-axis are the high-scoring TFBSs (i.e. of
instance score ≥ 6) that occur at least once in the 2 kb promoters of the miRNA up-regulated in DCs. The y-axis shows the number of promoters that
have the TFBS at least once at this threshold. (B) The distribution of the number of common TFBS hits per number of common miRNA promoters as in
A, for DCs and random sets of miRNA promoters. The values for random are the median values from 1000 randomly chosen sets of 12 miRNA
promoters. The score is the ratio of the sum of all TFBS occurrences across all promoters for the DC set relative to that of the random set. The p-value
is the fraction of cases wherein this sum for random sets of miRNA promoters is greater than or equal to that of the DC set.
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Figure 4 Distribution and evolutionary conservation of TFBSs in promoter regions of DC-expressed miRNAs. (A) The TFBS motif scores
(in blue, y-axis range from 0 to 15 per subgraph) as calculated using Clover and the extent of evolutionary conservation as PhastCons score (in
grey, y-axis on the right). (B) Distribution pattern of TFBSs, selected based on various motif score and evolutionary score thresholds, in the
promoter region of miRNAs up-regulated in DCs. (C) Comparison of the median conservation scores of the bases in the predicted TFBSs in the
promoters of miRNAs that are over-expressed in DCs, with those of randomly chosen sequences of the same length from the same promoters.
Boxplots represent the median and interquartile range of the median PhastCons conservation scores. The fold shown is the ratio of the median
of the DC conservation scores and the median of the conservation scores of the random sets (n = number of TFBS instances concerned).
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TargetScan and PicTar respectively, to be targets for the
miRNAs that are over-expressed in monocytes. For both
DC-over-expressed miRNAs and monocyte-over-
expressed miRNAs, the overlap of targets predicted by
both TargetScan and PicTar is less than 50% of their
respective total predictions (Additional file 14, Figure S6)
suggesting that we still need to examine their indepen-
dent predictions. Interestingly, only 7 identical targets
were predicted for both monocyte-over-expressed
miRNAs and DC-over-expressed miRNAs at the TargetS-
can threshold of ≤-0.4 and PicTar threshold of ≥0.4. The
numbers of target genes predicted are summarized in
Additional file 14, Figure S6.
The number of target genes predicted using TargetS-
can and PicTar are very large even at the stringent
thresholds used. Furthermore, Gene Ontology (GO) ana-
lyses of the gene sets did not yield conclusive results. To
increase the relevance of the predicted targets to DCs
A
    B
Figure 5 (A) Degree to which conserved TFBSs in promoter regions of miRNAs up-regulated in DCs are shared among their
promoters. (B) The distribution of the number of common TFBS hits per number of common miRNA promoters as in A, for test and random
sets of miRNA promoters. (A) Degree to which conserved TFBSs in promoter regions of miRNAs up-regulated in DCs are shared among their
promoters. Shown on the x-axis are high-scoring TFBSs filtered at a motif instance score threshold of at least 6 and at a 10th percentile
evolutionary conservation score that occur at least once in the promoters of miRNAs up-regulated in DCs. The y-axis shows the number of
promoters that have the TFBS at least once at these thresholds. (B) The distribution of the number of common TFBS hits per number of
common miRNA promoters as in A, for test and random sets of miRNA promoters. The values for random are the median values from 1000
random sets of miRNA promoters of the same size and length as those in the DC set. The score is the ratio of the sum of all occurrences of
conserved TFBS for the DC set relative to that of the random sets. The p-value is estimated from the number of instances wherein this sum for
1000 random sets of miRNA promoters is greater than or equal to that of the DC set.
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we further filtered them based on their differential
expression in DCs relative to monocytes during DC dif-
ferentiation using previously published data by Lehtonen
et al (2007) [47]. At a gene expression fold change
threshold of 2, we identified 34 unique genes corre-
sponding to the DC-associated targets predicted using
PicTar to be down-regulated at all time points in DCs
relative to monocytes (Additional file 15, Table S9A).
Amongst this filtered set of genes is IL10, which inter-
estingly is involved in the process of “negative regulation
of myeloid dendritic cell activation” (p = 2.64 × 10-2,
from GO analysis of the 34 down-regulated genes). Cor-
respondingly, 10 unique genes were associated with the
down-regulated genes of the TargetScan-predicted tar-
gets of miRNAs that were over-expressed in DCs rela-
tive to monocytes (Additional file 15, Table S9B). In
total, 6 of these down-regulated genes (SIK1, PELI2,
MYLIP, RNF138, CCNG2 and FOXO1; in order of
increasing down-regulation of their RNA transcripts at
time point 24 hr) were also predicted using PicTar
(Additional file 15, Table S9). Of these, SIK1, PELI2 and
one transcript of CCNG2 were increasingly down-regu-
lated in DCs relative to monocytes in the time course of
DC differentiation from monocytes; suggesting their
involvement in mechanisms of DC differentiation.
In addition to the DC dataset, we also examined the
expression of the predicted target genes of the miRNAs
that are over-expressed in monocytes relative to DCs. We
found 35 unique genes associated with the PicTar-pre-
dicted targets of miRNAs over-expressed in monocytes
relative to DCs that were down-regulated in monocytes
relative to DCs (Additional file 16, Table S10A). Corre-
spondingly, transcripts of 9 unique genes associated with
the TargetScan-predicted targets of miRNA over-
expressed in monocytes relative to DCs were also down-
regulated at all time points in monocytes relative to DCs
(Table S10B). Among these is DICER1 which is involved
in RNA interference and is up-regulated in DCs. Further-
more, there was an overlap of 2 genes (ACVR2A and
MAP3K4) between the PicTar and TargetScan target gene
sets (Additional file 14, Figure S6 and Additional file 17,
Table S11). One transcript of ACVR2A was increasingly
down-regulated (Additional file 16, Table S10). Moreover,
there was no overlap in expressed genes that were targets
to both DC- and monocyte-over-expressed miRNAs, sug-
gesting congruency in our data. These results suggest that
miRNA target genes can be either up-regulated or down-
regulated in myeloid cells to regulate differentiation of the
myeloid cells.
Discussion
As little is known about the expression and regulation
of miRNAs in monocytes, DCs and their stimulated pro-
geny, part of the miRNA transcriptome of these cells
was generated and analyzed. Out of 157 miRNAs pro-
filed, 104 appeared to be expressed in myeloid cells to a
varying degree. Since the database miRBase 13.0 (March
2009) reveals the existence of at least 706 human miR-
NAs, it is conceivable that a much higher number of
miRNAs is expressed in human monocytes and DCs. Six
miRNAs appear up-regulated in monocytes, 10 are up-
regulated in DCs and 3 are differentially expressed
among different DC populations in response to LPS.
Also, some miRNAs showed similar changes in expres-
sion levels among DC subsets.
Amongst the 10 miRNAs that were over-expressed in
DCs as compared to the monocytes from which they
were derived, hsa-miR-34a, hsa-miR-125a, hsa-miR-342
and hsa-let-7e have been shown to be up-regulated in
the course of DC differentiation from monocytes in cul-
ture [55,56]. The up-regulation of hsa-miR-342 in
monocyte-derived DCs as compared to monocytes is
likely the result of culture conditions, as hsa-miR-342 is
expressed at a much lower level in freshly isolated
blood-derived myeloid DCs than in DCs generated in
vitro (data not shown). Of the remaining miRNAs, 6
show an upward trend in expression level in blood-
derived DCs, but the levels in cultured DCs are higher.
Intriguingly, hsa-miR-146a and hsa-miR-155 appear to
respond to LPS, but much less so than in monocytes
and macrophages [7,8]. Recently, it was demonstrated
that LPS-mediated activation of protein kinase Akt1
results in up-regulation of miRNA let-7e in primary
macrophages, while at the same time repressing miR-
155 expression [57]. Our data show that both hsa-let-7e
and hsa-miR-155 are up-regulated in DCs compared to
monocytes, but that only hsa-miR-155 is slightly up-
regulated by LPS. Taken together, these data imply that
intrinsic differences between DCs and macrophages
exist in response to the TLR4 ligand LPS.
With regard to the targets of the miRNAs screened
herein, recent literature indicates that inhibition of hsa-
miR-34a or addition of one of its target genes, JAG1,
have been observed to functionally stall the differentia-
tion of monocyte-derived dendritic cells [55]. This sup-
ports our identification of hsa-miR-34a as an over-
expressed miRNA in DCs relative to monocytes and
JAG1 as its target gene (NM_000214 in Additional file
11, Table S6). In addition, we provide a list of predicted
DC targets that are down-regulated in expression in
DCs relative to monocytes (Additional file 15, Table S9).
In this list, one of the targets of the DC-expressed
miRNA, hsa-let-7e, is IL10, which is involved in negative
regulation of myeloid dendritic cell activation. Taken
together, these data highlight miRNAs, and their target
genes, that can potentially modulate DC differentiation.
Extensive miRNA promoter analysis revealed that 13
TFBSs are over-represented and commonly shared by
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the 12 promoter sequences of the 10 miRNAs that are
up-regulated in DCs. These include signal transducer
and activator of transcription 6 (STAT6), which is
known to be involved in IL4 signaling and DC differen-
tiation and maturation [58], spleen focus forming virus
(SFFV) proviral integration oncogene spi1 (SPI1, also
known as PU.1), which is indispensable for normal mye-
loid and lymphoid development [59] and specificity pro-
tein 1 (SP1), which is involved in the expression of
dendritic cell-specific ICAM-3 grabbing non-integrin
(DC-SIGN) [60].
Although the TSSs in these promoter regions are not
known, TFBSs did cluster, especially when taking evolu-
tionary conservation into account, within the 500 bp
upstream region of the annotated pre-miRNAs, coincid-
ing with the region in miRNA promoters at which TSS
have been discovered experimentally [19,61]. Amongst
the TFBSs predicted in the DC miRNAs, the sites for
myeloid zinc finger (MZF1) is best conserved of all, even
though the role of its cognate TF in DCs remains elu-
sive. Nevertheless, MZF1 is thought to be a bi-functional
transcriptional regulator, repressing transcription in
non-hematopoietic cells, activating transcription in cells
of hematopoietic origins and controlling cell prolifera-
tion and tumorigenesis [62,63]. In addition, one of the
conserved TFBSs for which the cognate TF was not
expressed in monocyte-derived DCs appears to be Spi-B
transcription factor (SPIB), which has been implicated in
plasmacytoid DC (pDC) development, a non-myeloid
cell type [64,65]. It should be noted, however, that many
of the miRNAs expressed in myeloid monocyte-derived
DCs are also expressed in pDCs (data not shown).
When taking all predicted and well-conserved TFBSs
in the promoters of miRNAs that are up-regulated in
DCs into account, the number of TFs expressed
increases with the degree at which their TFBS motifs
are shared between the promoter sequences. Gene
Ontology analysis indicates that the type of expressed
TFs enriched in these data are relevant to the immune
system process and are in line with the known function
of DCs, whereas those that were not expressed are rele-
vant to cell development (Additional file 9, Table S4).
Importantly, libraries of TFBS motifs used do not repre-
sent all possible TFBSs and as such not all possible
TFBSs for expressed miRNAs have been identified in
this study. Moreover, for consistency, we have used
TFBS motifs, and not TFs, in making comparisons of
TFBSs because the databases used have redundant motif
names for the same TFs. It should be noted that pre-
dicted target genes were not uniformly down-regulated,
as we found evidence in DCs whereby predicted target
genes were up-regulated in the cells or were also targets
for the miRNAs that were over-expressed in monocytes.
This may be due to limitations of the target prediction
algorithms, or the targets might still be down-regulated
at the protein level. Nevertheless, none of the down-
regulated DC-miRNA targets was a predicted target for
the monocyte-miRNAs. Furthermore, there is evidence
that in a minority of cases, target genes are actually up-
regulated by miRNAs [66,67]. The up-regulation of
DICER1 in DCs relative to monocytes is of special inter-
est, as it is known that innate immune signaling is
tightly controlled by miRNAs [7,8]. Furthermore, there
is also evidence that one type of DC, the Langerhans
cell, requires proper functioning of DICER1 to induce
CD4 T cell function [68]. Together with the fact that
there are more up-regulated miRNAs in DCs than
monocytes in our data set, it is tempting to speculate
that DICER1 up-regulation is required for proper DC
function.
Conclusions
The data provide evidence that, among the many
expressed miRNAs in DCs, evolutionarily conserved
TFBSs relevant to DC biology are present in their pro-
moters. Furthermore, the identified miRNAs, their asso-
ciated TFs and predicted target genes could help
improve our understanding of the molecular pathways
that underpin DC differentiation and maturation.
Additional material
Additional file 1: Figure S1. Setup of culture and quality of monocyte-
derived DCs. (A) Culture setup and harvest schedule for RNA isolations.
(B) Purity of monocytes (upper histogram) and the expression of
maturation markers CD80 and CD86 on the different DC populations (C)
Mixed lymphocyte reaction with the various DC populations; ratio of DCs
vs. PBLs is indicated on the x-axis. (D) Production of TNFa and IL8 by the
different DC populations, as determined by ELISA. The white and black
bars each represent data from two different donors.
Additional file 2: Figure S2. Schematic overview of the miRNA
expression screen in monocytes and DCs.
Additional file 3: Table S1. MicroRNAs for which assays have been
developed by Applied Biosystems, and of which expression levels were
determined in monocytes and dendritic cells. Of a total of 157 miRNAs,
104 were expressed in DC and/or monocytes, whereas 53 were not
detected in either cell type.
Additional file 4: Table S2. Overview of over-represented TFBS motifs in
promoter seqeunces of miRNAs that are upregulated in monocytes or
DCs.
Additional file 5: Figure S3. (A) Commonality of TFBSs in promoter
regions of monocyte-expressed miRNAs. Shown on the x-axis are the
high-scoring TFBSs (i.e. of instance score ≥ 6) that occur at least once in
the 2 kb promoters of the miRNA up-regulated in monocytes. The y-axis
shows the number of promoters that have the TFBS, at least once at this
threshold. (B) The distribution of the number of common TFBS hits per
number of common miRNA promoters as in A, for test and random sets
of miRNA promoters. The values for random are the median values from
1000 random set of miRNA promoters of same size and length as those
in the monocyte set. The score is the ratio of the sum of “the product of
numbers on the x-axis and corresponding y-axis values” for the
monocyte set relative to that of the random. The p-value is the fraction
of cases wherein this sum for random sets of miRNA promoters is
greater than or equal to that of the DC set.
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Additional file 6: Figure S4. (A) TFBSs shared among the promoter
regions of miRNAs up-regulated in monocytes. Shown on the x-axis are
high-scoring TFBSs filtered at a motif instance score threshold of atleast
6 and at a 10th percentile evolutionary conservation score that occur at
least once in the promoters of miRNAs up-regulated in DCs. The y-axis
shows the number of promoters that have the TFBS at least once at
these thresholds. (B) The distribution of the number of common TFBS
hits per number of common miRNA promoters as in A, for test and
random sets of miRNA promoters. The values for random are the median
values from 1000 random set of miRNA promoters of same size and
length as those in the monocyte set. The score is the ratio of the sum of
all occurrences of all TFBS for the monocyte set relative to that of the
random sets. The p-value is estimated from the number of instances
wherein this sum of “the product of number of TFBSs and the number
of miRNA promoters” of 1000 random sets of miRNA promoters is
greater than or equal to that of the monocyte set.
Additional file 7: Table S3. Library of TFBS motif for which the cognate
TFs are expressed (presence = 1) or not expressed (absence = 1) in DCs.
Additional file 8: Figure S5. Correlation of the number of expressed TFs
with the number of promoters of miRNAs that are over-expressed in
DCs. The TFs used are those of high-scoring TFBSs (i.e. of instance score
> = 6) that are also highly conserved (10th percentile of PhastCons
scores) and occur at least once in the 2 kb promoters of the miRNA up-
regulated in DCs (left plot), and a random set of miRNAs (right plot). The
original number of miRNA promoters that share at least one TFBS was 12
for both DCs and the random set of promoters (i.e the number of
promoters of miRNAs that were over-expressed in DCs). Due to the high
conservation threshold used, the maximum number of miRNA promoters
that share at least one TFBS became smaller (6 for the test set and 3 for
the random set). The correlations were calculated using the Pearson
correlation as implemented in R.
Additional file 9: Table S4. Gene ontology analysis of the expressed
and not-expressed TFs of predicted binding sites in the promoters of
miRNA.
Additional file 10: Table S5. The 421 target genes that are predicted by
TargetScan for the DC-over-expressed miRNAs.
Additional file 11: Table S6. The 2300 target genes that are predicted
by PicTar for the DC-over-expressed miRNAs.
Additional file 12: Table S7. The 282 target genes that are predicted by
TargetScan for the Monocyte-over-expressed miRNAs.
Additional file 13: Table S8. The 1591 target genes that are predicted
by PicTar for the Monocyte-over-expressed miRNAs.
Additional file 14: Figure S6. Venn diagram showing the intersection of
target genes. (A) Intersection of target genes of the miRNAs that are
over-expressed in DCs, using PicTar (DC.pic), and TargetScan (DC.tar). (B)
Similar to A, but for monocytes. (C) Intersections of the common targets
found by PicTar and TargetScan for DC miRNAs (DC.pic.tar), the common
targets for monocyte miRNAs (mono.pic.tar), and the dataset of
Lehtonen et al. 2007 (Leh.) of genes that are regulated in DCs relative to
monocytes during DC differentiation. (D-F) Intersection of common
target genes from DC miRNAs, monocyte miRNAs, and genes that were
up-regulated (upreg) or down-regulated (downreg), in DCs relative to
monocytes in the data set of Lehtonen et al.2007. Figure D, E, F
represent respectively the data sets at time points 3, 6 and 24 hr of DC
differentiation from monocytes. (Differential gene relations (DC/
monocyte) were selected at a fold change of at least 2. The PicTar score
used > = 0.4, TargetScan context score < = -0.4. Comparisons were done
at the level of RefSeq DNA ID and the elements in the intersections with
the upreg and downreg datasets are provided in Table S11 with gene
symbols attached.
Additional file 15: Table S9. Target genes that are down-regulated in
DCs relative to monocytes and that were predicted using PicTar or
Targetscan, to be targets of miRNAs that are over-expressed in DCs
relative to monocytes.
Additional file 16: Table S10. Target genes that are down-regulated in
monocytes relative to DCs and that were predicted using PicTar or
Targetscan, to be targets of miRNAs that are over-expressed in
monocytes relative to DCs.
Additional file 17: Table S11. Elements in the Venn diagram
intersection of Figure S6D to S6F.
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